Psychiatric Disorders
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: <for patients> 1) Participants who are eighteen years of age or older and younger than seventy years of age at the time of screening 2) Participants who are diagnosed with the relevant psychiatric disorder according to the DSM-5 diagnostic criteria <for healthy controls> 1) Participants who are eighteen years of age or older and younger than seventy years of age at the time of screening
Exclusion criteria
Exclusion criteria: <for patients> 1) Participants for whom the investigator determines at screening that completion of the study is not feasible. <for healthy controls> 1) Participants with a current or past history of psychiatric disorders. 2) Participants for whom the investigator determines at screening that completion of the study is not feasible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| None prespecified (exploratory analyses only) | — |
Secondary
| Measure | Time frame |
|---|---|
| None; exploratory analyses only. | — |
Countries
Japan
Contacts
Otsuka Pharmaceutical Co., Ltd. HQ of Clinical Development